A MedPage Today article cited dietary modification, rifaximin and Boca Raton, Fla.-based IM HealthScience’s IBgard as the disease’s three effective interventions.
Here are three things to know:
1. Los Angeles-based Cedars-Sinai Medical Center Assistant Director Ali Rezaie, MD, said dietary restriction is a difficult option because “dietary restriction can affect quality of life, sometimes more than the [IBS-M] symptoms themselves.”
2. Dr. Rezaie argued alternating laxatives and anti-diarrheal medication complicates the situation.
3. Several providers praised IBgard’s ability to treat IBS-M.
More articles on gastroenterology/endoscopy:
LifeBond enrolling patients in LifeSeal surgical sealant study: 4 key notes
GI leader to know: Dr. Sam Moussa of Adobe Gastroenterology
5 ways CMS changes are affecting reimbursement for ASCs, anesthesia practices and providers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.